VIR-3434 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

University Health Network, Toronto1

Indications

Liver Disease1
Hepatitis B, Chronic1

Other1 trial

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.